The forecast for pancreas malignant neoplasms mortality in Canada suggests a gradual increase from 14.7 deaths per hundred thousand persons in 2024 to 15.3 in 2028. Year-on-year growth in mortality rate shows an average rise of approximately 0.2 deaths per 100,000 people, representing a stable growth trend of about 1.4% annually. The compound annual growth rate (CAGR) over five years is also roughly 1.4%, indicating consistent upward pressure on mortality rates due to pancreas malignant neoplasms.
Future trends to watch for include the impact of healthcare advancements on early detection and treatment of pancreatic cancer, which could affect mortality rates. Additionally, demographic shifts such as aging populations and lifestyle-related risk factors may continue to influence these figures. Long-term surveillance of risk factor modifications and healthcare policy changes are essential for mitigating these trends.
